25 results

• Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects

  September 4, 2024

  Irvin Jackson

  Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.

• BioZorb Injury Lawsuits Are Being Prepared For Trial in July 2025 in District of Massachusetts

  August 14, 2024

  Irvin Jackson

  A group of four lawsuits over the BioZorb marker will be selected for a series of early bellwether trial dates starting in July 2025, which are designed to help gauge how juries may respond to evidence that will be repeated throughout claims that the tissue marker caused painful complication.

• BioZorb Implant Complications Result in Lawsuit Brought by 7 Breast Cancer Survivors

  July 26, 2024

  Irvin Jackson

  A Biozorb tissue marker lawsuit filed by seven women claim the implant is defectively designed, and prone to cause a variety of complications, such as pain, lumps, device migration and infections.

• BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal

  July 11, 2024

  Russell Maas

  A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

• BioZorb Marker Recall Issued After Dozens of Injuries Linked to the Radiographic Implants

  May 23, 2024

  Grace Muller

  Nearly 54,000 BioZorb Markers, used in breast cancer treatment, are being recalled following dozens of reports of injuries, including implant migration.